Revel Pharmaceuticals Launched
Glucosepane crosslink breaker research graduates from top Yale lab into the biotech world Kizoo Technology Capital leads seed round financing at Revel Pharmaceuticals SAN FRANCISCO/NEW HAVEN/BERLIN, Jan. 21, 2020 — For the past 10 years, Yale Professors David Spiegel and Jason Crawford have been working on tools to enable the development of glucosepane-cleaving drugs. Kizoo …